HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Analysts at Roth Capital boosted their Q4 2026 earnings per share (EPS) estimates for HIVE Blockchain Technologies in a report issued on Monday, January 6th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings of $0.04 per share for the quarter, up from their previous forecast of $0.03. Roth Capital has a “Strong-Buy” rating on the stock.
A number of other equities research analysts have also issued reports on HIV. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Thursday, September 19th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- Canadian Penny Stocks: Can They Make You Rich?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Compound Interest and Why It Matters When Investing
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
